Renaissance Technologies’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
489,300
+400,400
| +450% | +$2.19M | ﹤0.01% | 1926 |
|
|
2025
Q1 | $559K | Sell |
88,900
-11,500
| -11% | -$72.3K | ﹤0.01% | 2697 |
|
|
2024
Q4 | $414K | Buy |
100,400
+29,700
| +42% | +$122K | ﹤0.01% | 2930 |
|
|
2024
Q3 | $236K | Buy |
70,700
+18,800
| +36% | +$62.8K | ﹤0.01% | 3070 |
|
|
2024
Q2 | $155K | Sell |
51,900
-64,942
| -56% | -$194K | ﹤0.01% | 3100 |
|
|
2024
Q1 | $403K | Sell |
116,842
-425,858
| -78% | -$1.47M | ﹤0.01% | 2959 |
|
|
2023
Q4 | $727K | Buy |
542,700
+475,400
| +706% | +$637K | ﹤0.01% | 2585 |
|
|
2023
Q3 | $147K | Sell |
67,300
-22,000
| -25% | -$48.1K | ﹤0.01% | 3161 |
|
|
2023
Q2 | $213K | Sell |
89,300
-148,100
| -62% | -$353K | ﹤0.01% | 3280 |
|
|
2023
Q1 | $439K | Sell |
237,400
-80,600
| -25% | -$149K | ﹤0.01% | 2950 |
|
|
2022
Q4 | $614K | Sell |
318,000
-101,187
| -24% | -$195K | ﹤0.01% | 2833 |
|
|
2022
Q3 | $646K | Buy |
419,187
+267,687
| +177% | +$413K | ﹤0.01% | 2766 |
|
|
2022
Q2 | $426K | Buy |
151,500
+35,500
| +31% | +$99.8K | ﹤0.01% | 3249 |
|
|
2022
Q1 | $255K | Sell |
116,000
-221,400
| -66% | -$487K | ﹤0.01% | 3543 |
|
|
2021
Q4 | $264K | Buy |
337,400
+271,900
| +415% | +$213K | ﹤0.01% | 3400 |
|
|
2021
Q3 | $92K | Sell |
65,500
-27,100
| -29% | -$38.1K | ﹤0.01% | 3330 |
|
|
2021
Q2 | $208K | Sell |
92,600
-29,249
| -24% | -$65.7K | ﹤0.01% | 3236 |
|
|
2021
Q1 | $330K | Buy |
121,849
+96,149
| +374% | +$260K | ﹤0.01% | 3030 |
|
|
2020
Q4 | $62K | Buy |
+25,700
| New | +$62K | ﹤0.01% | 3308 |
|